AU2016236187B2 - Inhibitors of Pseudomonas aeruginosa LecB - Google Patents

Inhibitors of Pseudomonas aeruginosa LecB Download PDF

Info

Publication number
AU2016236187B2
AU2016236187B2 AU2016236187A AU2016236187A AU2016236187B2 AU 2016236187 B2 AU2016236187 B2 AU 2016236187B2 AU 2016236187 A AU2016236187 A AU 2016236187A AU 2016236187 A AU2016236187 A AU 2016236187A AU 2016236187 B2 AU2016236187 B2 AU 2016236187B2
Authority
AU
Australia
Prior art keywords
group
unsubstituted
alkyl group
alkyl
coor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016236187A
Other languages
English (en)
Other versions
AU2016236187A1 (en
Inventor
Roman SOMMER
Alexander TITZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum fuer Infektionsforschung HZI GmbH filed Critical Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Publication of AU2016236187A1 publication Critical patent/AU2016236187A1/en
Application granted granted Critical
Publication of AU2016236187B2 publication Critical patent/AU2016236187B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016236187A 2015-03-24 2016-03-24 Inhibitors of Pseudomonas aeruginosa LecB Active AU2016236187B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15160612.6 2015-03-24
EP15160612 2015-03-24
PCT/EP2016/056486 WO2016151066A1 (en) 2015-03-24 2016-03-24 Inhibitors of pseudomonas aeruginosa lecb

Publications (2)

Publication Number Publication Date
AU2016236187A1 AU2016236187A1 (en) 2017-10-12
AU2016236187B2 true AU2016236187B2 (en) 2020-05-21

Family

ID=52706073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016236187A Active AU2016236187B2 (en) 2015-03-24 2016-03-24 Inhibitors of Pseudomonas aeruginosa LecB

Country Status (7)

Country Link
US (1) US10407398B2 (enExample)
EP (1) EP3274341B1 (enExample)
JP (2) JP6862410B2 (enExample)
CN (1) CN107531686B (enExample)
AU (1) AU2016236187B2 (enExample)
IL (1) IL254580B (enExample)
WO (1) WO2016151066A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7430381B2 (ja) * 2020-02-04 2024-02-13 水谷ペイント株式会社 バイオフィルム破壊能の評価方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013152848A1 (en) * 2012-04-10 2013-10-17 Universität Konstanz Glycomimetics as pseudomonas aeruginosa lectin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5789385A (en) * 1993-06-16 1998-08-04 Glycomed Incorporated Sialyl Lewisx mimetics containing phenyl backbones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013152848A1 (en) * 2012-04-10 2013-10-17 Universität Konstanz Glycomimetics as pseudomonas aeruginosa lectin inhibitors

Also Published As

Publication number Publication date
CA2980406A1 (en) 2016-09-29
WO2016151066A1 (en) 2016-09-29
CN107531686A (zh) 2018-01-02
US20180155310A1 (en) 2018-06-07
JP6862410B2 (ja) 2021-04-21
US10407398B2 (en) 2019-09-10
EP3274341A1 (en) 2018-01-31
IL254580B (en) 2020-11-30
IL254580A0 (en) 2017-11-30
JP2021046411A (ja) 2021-03-25
CN107531686B (zh) 2021-07-09
EP3274341B1 (en) 2022-11-02
JP2018510908A (ja) 2018-04-19
AU2016236187A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
KR102081444B1 (ko) 신규의 바이러스 복제 저해제
CN108530310B (zh) 2-(取代苯杂基)芳香甲酸类fto抑制剂，其制备方法及其应用
KR20190052113A (ko) 알키닐-치환된 헤테로시클릭 화합물, 이의 제조 방법 및 이의 의약 용도
CN102134218A (zh) 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
KR102752564B1 (ko) 아데노신 수용체 길항제 화합물
KR20180128937A (ko) 질환을 치료하는데 유용한 fimh의 만노스-유래 길항제
JP2017516821A (ja) ナフチリジンジオン誘導体
EP3720438B1 (en) Heterocycle substituted pyridine derivative antifungal agents
AU2016236187B2 (en) Inhibitors of Pseudomonas aeruginosa LecB
WO2020163479A1 (en) Antibiotic ammonium compounds and methods for the treatment of bacterial infections
EP1134219B1 (en) Cycloalkyl-substituted aminomethylpyrrolidine derivatives
CN119775277A (zh) 用于治疗例如自身免疫性疾病的作为lrrk2、nuak1和/或tyk2激酶调节剂的化合物
WO2020247804A1 (en) Heterocycle substituted pyridine derivative antifungal agents
KR20240097839A (ko) LpxC 억제제 및 이의 용도
CA2980406C (en) 1-deoxy-fucose derivatives as inhibitors of pseudomonas aeruginosa lecb
WO2016199105A1 (en) Mannose derivatives for treating bacterial infections
CN113149990B (zh) 铁载体-二氢叶酸还原酶抑制剂偶联物及其应用
CA3235292A1 (en) Tricyclic boronic acid derivative, and preparation method therefor and application thereof
CN116514805A (zh) Mettl3抑制剂化合物
CN116478150A (zh) 具有ripk1抑制活性的化合物、其制备方法及其用途
EP4054715A1 (en) Bivalent leca inhibitors targeting biofilm formation of pseudomonas aeruginosa
WO2018199797A1 (ru) Замещенные 2-метилиден-5-(фениламино)-2,3-дигидротиофен-3-оны для лечения лейкозов с транслокациями mll-гена и других онкологических заболеваний
WO2025177150A1 (en) Compound as parp1 inhibitor and pharmaceutical composition comprising the same
KR20160068783A (ko) 반코마이신-당 접합체 및 그의 용도
HK1037635B (en) Cycloalkyl-substituted aminomethylpyrrolidine derivatives

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)